BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21949152)

  • 1. The use of systemic and topical fluoroquinolones.
    Bradley JS; Jackson MA; ;
    Pediatrics; 2011 Oct; 128(4):e1034-45. PubMed ID: 21949152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Use of Systemic and Topical Fluoroquinolones.
    Jackson MA; Schutze GE;
    Pediatrics; 2016 Nov; 138(5):. PubMed ID: 27940800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoroquinolone antibiotics in infants and children.
    Schaad UB
    Infect Dis Clin North Am; 2005 Sep; 19(3):617-28. PubMed ID: 16102652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Will fluoroquinolones ever be recommended for common infections in children?
    Schaad UB
    Pediatr Infect Dis J; 2007 Oct; 26(10):865-7. PubMed ID: 17901790
    [No Abstract]   [Full Text] [Related]  

  • 5. The newer fluoroquinolones.
    Bolon MK
    Infect Dis Clin North Am; 2009 Dec; 23(4):1027-51, x. PubMed ID: 19909896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of systemic fluoroquinolones.
    Committee on Infectious Diseases
    Pediatrics; 2006 Sep; 118(3):1287-92. PubMed ID: 16951028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoroquinolones: then and now.
    Pallo-Zimmerman LM; Byron JK; Graves TK
    Compend Contin Educ Vet; 2010 Jul; 32(7):E1-9; quiz E9. PubMed ID: 20957609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA and the safe and appropriate antibiotic use of fluoroquinolones.
    Tillotson GS
    Lancet Infect Dis; 2016 Mar; 16(3):e11-2. PubMed ID: 26973315
    [No Abstract]   [Full Text] [Related]  

  • 9. The safety profile of moxifloxacin and other fluoroquinolones in special patient populations.
    Iannini PB
    Curr Med Res Opin; 2007 Jun; 23(6):1403-13. PubMed ID: 17559736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical fluoroquinolones for eye and ear.
    Morden NE; Berke EM
    Am Fam Physician; 2000 Oct; 62(8):1870-6. PubMed ID: 11057842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of complicated urinary tract infections in the era of antimicrobial resistance.
    Bader MS; Hawboldt J; Brooks A
    Postgrad Med; 2010 Nov; 122(6):7-15. PubMed ID: 21084776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical position of sitafloxacin in outpatient chemotherapy. (discussion)].
    Niki Y; Aoki N; Suzuki K; Matsumoto T
    Jpn J Antibiot; 2009 Jun; 62(3):179-93. PubMed ID: 19882979
    [No Abstract]   [Full Text] [Related]  

  • 13. Bacterial resistance in the new millennium. Its impact on antibiotic selection for respiratory tract infections.
    Appelbaum PC
    Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):5-16. PubMed ID: 19667544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appropriate use of fluoroquinolones in children.
    Principi N; Esposito S
    Int J Antimicrob Agents; 2015 Apr; 45(4):341-6. PubMed ID: 25726705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of antibacterial prophylaxis for patients with neutropenia. Australian Consensus Guidelines 2011 Steering Committee.
    Slavin MA; Lingaratnam S; Mileshkin L; Booth DL; Cain MJ; Ritchie DS; Wei A; Thursky KA;
    Intern Med J; 2011 Jan; 41(1b):102-9. PubMed ID: 21272174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appropriate antibiotic use and why it is important: the challenges of bacterial resistance.
    Lieberman JM
    Pediatr Infect Dis J; 2003 Dec; 22(12):1143-51. PubMed ID: 14688589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fluoroquinolones use at the Saint-Louis Hospital: investigations before and after diffusion of recommendations and interventions of the anti-infectious referent].
    Politis B; Pagnon V; Lescot C; Faure P; Touratier S; Lafaurie M
    Pathol Biol (Paris); 2010 Dec; 58(6):415-9. PubMed ID: 19200663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context.
    Ball P; Mandell L; Patou G; Dankner W; Tillotson G
    Int J Antimicrob Agents; 2004 May; 23(5):421-9. PubMed ID: 15120718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of gemifloxacin in the management of community-acquired lower respiratory tract infections.
    Blondeau JM; Tillotson G
    Int J Antimicrob Agents; 2008 Apr; 31(4):299-306. PubMed ID: 18276120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The perils of prescribing fluoroquinolones.
    Heidelbaugh JJ; Holmstrom H
    J Fam Pract; 2013 Apr; 62(4):191-7. PubMed ID: 23570031
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.